Outcome of tyrosinaemia type III
- PMID: 11916315
- DOI: 10.1023/a:1013936107064
Outcome of tyrosinaemia type III
Abstract
Tyrosinaemia type III is a rare disorder caused by a deficiency of 4-hydroxyphenylpyruvate dioxygenase, the second enzyme in the catabolic pathway of tyrosine. The majority of the nine previously reported patients have presented with neurological symptoms after the neonatal period, while others detected by neonatal screening have been asymptomatic. All have had normal liver and renal function and none has skin or eye abnormalities. A further four patients with tyrosinaemia type III are described. It is not clear whether a strict low tyrosine diet alters the natural history of tyrosinaemia type III, although there remains a suspicion that treatment may be important, at least in infancy.
Similar articles
-
Tyrosinemia Type III detected via neonatal screening: management and outcome.Mol Genet Metab. 2012 Nov;107(3):605-7. doi: 10.1016/j.ymgme.2012.09.002. Epub 2012 Sep 7. Mol Genet Metab. 2012. PMID: 23036342
-
Mutations in the 4-hydroxyphenylpyruvate dioxygenase gene (HPD) in patients with tyrosinemia type III.Hum Genet. 2000 Jun;106(6):654-62. doi: 10.1007/s004390000307. Hum Genet. 2000. PMID: 10942115
-
Predicting tyrosinaemia: a mathematical model of 4-hydroxyphenylpyruvate dioxygenase inhibition by nitisinone in rats.Math Med Biol. 2017 Sep 1;34(3):335-390. doi: 10.1093/imammb/dqw006. Math Med Biol. 2017. PMID: 27305933
-
Recommendations for the management of tyrosinaemia type 1.Orphanet J Rare Dis. 2013 Jan 11;8:8. doi: 10.1186/1750-1172-8-8. Orphanet J Rare Dis. 2013. PMID: 23311542 Free PMC article. Review.
-
Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione).J Inherit Metab Dis. 1998 Aug;21(5):507-17. doi: 10.1023/a:1005410820201. J Inherit Metab Dis. 1998. PMID: 9728331 Review.
Cited by
-
Novel Cranial Imaging Findings and a Splice-Site Variant in a Patient with Tyrosinemia Type III, and a Summary of Published Cases.Mol Syndromol. 2022 May;13(3):193-199. doi: 10.1159/000519256. Epub 2022 Jan 4. Mol Syndromol. 2022. PMID: 35707594 Free PMC article.
-
TYROSINEMIA TYPE III: A CASE REPORT OF SIBLINGS AND LITERATURE REVIEW.Rev Paul Pediatr. 2020 Jun 5;38:e2018158. doi: 10.1590/1984-0462/2020/38/2018158. eCollection 2020. Rev Paul Pediatr. 2020. PMID: 32520295 Free PMC article. Review.
-
Alkaptonuria.Nat Rev Dis Primers. 2024 Mar 7;10(1):16. doi: 10.1038/s41572-024-00498-x. Nat Rev Dis Primers. 2024. PMID: 38453957 Review.
-
Ochronotic arthropathy as a paradigm of metabolically induced degenerative joint disease. A case-based review.Clin Rheumatol. 2016 May;35(5):1389-95. doi: 10.1007/s10067-014-2557-7. Epub 2014 Mar 20. Clin Rheumatol. 2016. PMID: 24647979 Review.
-
Biallelic variants in HPDL cause pure and complicated hereditary spastic paraplegia.Brain. 2021 Jun 22;144(5):1422-1434. doi: 10.1093/brain/awab041. Brain. 2021. PMID: 33970200 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical